Paradromics' first BCI user generates real-time speech as trial adds personal devices
Founder Matt Angle's decade-long effort is moving from neural recordings toward daily communication, though Connexus remains investigational and human evidence is early.
By RuntimeWire Staff · Published
Primary source: Forbes
Why it matters
Paradromics is testing whether an implanted BCI can move from a lab demonstration toward communication and device control in daily life. Its first real-time speech result is a meaningful early milestone, while the investigational study still has to establish safety, reliability and performance across more participants.
Paradromics founder and CEO Matt Angle has spent years trying to move high-resolution brain recordings out of research labs and into a medical device. In September, the first participant in Paradromics' study used its implanted Connexus system to generate real-time speech; an FDA study expansion announced in August also lets study participants use compatible personal laptops, tablets and phones with the system.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.